Comparing the results of using strut bone graft from the iliac bone and cancellous bone graft from the iliac bone on large bone defects in the lower body

ISRCTN ISRCTN99236054
DOI https://doi.org/10.1186/ISRCTN99236054
Secondary identifying numbers 2021-05-039
Submission date
13/02/2023
Registration date
15/03/2023
Last edited
28/02/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
This study is looking at a new way to fix large bone defects in the lower body using bone graft from the iliac bone. In the past, using simple bone grafting has not been successful for fixing large bone defects. This study will compare using a strut-type bone graft from the iliac bone to using a cancellous bone graft from the iliac bone. The goal is to see if the strut-type bone graft is a good solution with fewer complications.

Who can participate?
Patients over 18 years of age with bone defects in the long bones of the lower extremity, treated by autogenous iliac bone graft (AIBG)

What does the study invlove?
Analyzing the outcomes of autogenous strut bone graft in large bone defects of ≥ 5 cm in the lower extremities and to compare it with the autogenous cancellous bone graft, which is accepted as the golden standard of treatment in bone defects of < 5 cm.

What are the possible benefits and risks of participating?
You can receive specialized treatment for bone defects in the lower limbs. Complications may occur during treatment, including infection, bleeding, pain, and damage to nerves and blood vessels.

Where is the study run from?
Hanyang University Seoul Hospital, 222-1 Wangsimni-ro, Seongdong-gu, Seoul 04763 KOREA

When is the study starting and how long is it expected to run for?
This study is a retrospective study, and all data collection and analysis were completed in December 2021, starting with the study design plan in December 2019.

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Professor Kyu Tae Hwang, M.D, Ph.D.
md0713@hanmail.net

Contact information

Prof Kyu Tae Hwang
Principal Investigator

Department of Orthopaedic Surgery
Hanyang University College of Medicine
222 Wangsimni-ro
Seongdong-gu
Seoul
04763
Korea, South

Phone +82-2-2290-8485
Email md0713@hanmail.net
Dr Incheol Kook
Public

Department of Orthopaedic Surgery
Hanyang University College of Medicine
222 Wangsimni-ro
Seongdong-gu
Seoul
04763
Korea, South

ORCiD logoORCID ID 0000-0001-8691-5495
Phone +82-2-2290-8485
Email nathan0319@naver.com

Study information

Study designSingle center interventional non-randomized retrospective cohort study
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Hospital, Medical and other records
Study typeTreatment
Participant information sheet Not applicable (retrospective study)
Scientific titleThe impact of autogenous iliac strut bone graft on large bone defect of lower extremity compared with autogenous iliac cancellous bone graft: a retrospective cohort study
Study acronymStrut AIBG
Study objectivesAutogenous bone graft in strut form might show favorable union rate in large bone defects of ≥ 5 cm with minimal complications
Ethics approval(s)Approved 02/05/2021, Hanyang University Hospital Instituional review board (222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, South KOREA; +82 (2)2290 9651; icshin@hanyang.ac ), ref: HYUH 2021-05-039
Health condition(s) or problem(s) studiedPerforming autogenous strut bone graft in patients with large bone defects of ≥ 5 cm in the lower extremities.
InterventionBased on the types of the grafted bone, the patients were classified into two groups: strut bone graft group and cancellous bone graft group. All bone grafts were harvested along the anterior iliac crest through the anterior approach. The strut-type corticocancellous bone graft was harvested using an osteotome, and a cortical window was used for harvesting the cancellous bone graft. Strut bone graft was performed only when the bone defect length was ≥ 5 cm. All of the bone graft procedures were performed by a single orthopedic trauma surgeon.
Intervention typeProcedure/Surgery
Primary outcome measureUnion and time to union were evaluated using a Radiographic Union Scale of Tibial Fractures (RUST) at 1, 2, 3, 6, 9, and 12 months postoperatively.
Secondary outcome measures1. Complications measured retrospective medical record review over admission and outpatient follow-up period
2. Reoperations measured using retrospective medical record review over admission and outpatient follow-up period
Overall study start date01/12/2019
Completion date01/12/2021

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants50
Total final enrolment50
Key inclusion criteria1. Bone defects in the long bones of the lower extremity
2. Bone defects treated by autogenous iliac bone graft
3. Age over 18 years
Key exclusion criteria1. Age younger than 18 years
2. Bone defects caused by pathologic fracture or tumor resection
3. Less than 12 months of follow-up period
Date of first enrolment23/03/2011
Date of final enrolment02/04/2020

Locations

Countries of recruitment

  • Korea, South

Study participating centre

Hanyang University Soeul Hospital
222-1 Wangsimni-ro
Seongdong-gu
Seoul
04763
Korea, South

Sponsor information

Hanyang University Seoul Hospital
Hospital/treatment centre

222 Wangsimni-ro
Seongdong-gu
Seoul
04763
Korea, South

Phone +82-2-2290-8485
Email irb@hyumc.com
Website https://seoul.hyumc.com/
ROR logo "ROR" https://ror.org/04n76mm80

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date30/04/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact journal
IPD sharing planThe datasets generated during and analysed during the current study will be available upon request from Kyu Tae Hwang, M.D., Ph.D, e-mail: md0713@hanmail.net

Editorial Notes

28/02/2023: Trial's existence confirmed by Hanyang University Hospital Instituional review board.